Santen Revenue and Competitors
Estimated Revenue & Valuation
- Santen's estimated annual revenue is currently $298.1M per year.
- Santen's estimated revenue per employee is $201,000
Employee Data
- Santen has 1483 Employees.
- Santen grew their employee count by -3% last year.
Santen's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head HR - EMEA, Asia & Medical Technology Solutions | Reveal Email/Phone |
2 | Head IT North America | Reveal Email/Phone |
3 | Head Supply Chain Management, EMEA | Reveal Email/Phone |
4 | Head Artwork Management | Reveal Email/Phone |
5 | Head, Global Patient Experience and Policy, Lead – In Service Patients (ISOP) | Reveal Email/Phone |
6 | VP, Alliances & Collaborations + Head Glaucoma / Neuroprotection Therapeutic Head | Reveal Email/Phone |
7 | Head Infrastructure, North American Region | Reveal Email/Phone |
8 | VP, Global Head Data Sciences & Biometrics, Santen | Reveal Email/Phone |
9 | Head Global Clinical Quality Assurance & Pharmcovigilance QA, N.America & EMA | Reveal Email/Phone |
10 | Head Global Commercial Strategy | Reveal Email/Phone |
Santen Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Santen?
At Santen, we’re innovating therapies to improve the quality of life for patients worldwide. Our single focus in ophthalmology enables us to challenge unmet needs in the field–through passionate research, successful collaboration, and clarity of commitment. With over 120 years of investigative insight, Santen remains committed to the discovery, exploration, and development of ophthalmic therapies. Now, and into the future. As a globally competitive company, Santen is often expanding to accommodate new and evolving initiatives in ophthalmic research, regulatory management, production, marketing, or distribution. Our clinical development network now spans three continents, with centers in Europe, Japan, and the United States. Santen World Wide http://www.santen.com/ Santen United States http://www.santeninc.com/ Santen Europe http://www.santen.eu/ Japan http://www.santen.co.jp/ Asia http://www.santen-china.oinsite.cn/ Ophthalmology
keywords:N/A
N/A
Total Funding
1483
Number of Employees
$298.1M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Santen News
Santen Pharmaceutical, Perrigo, Merck, Bayer, Akorn. Bacterial Conjunctivitis Drugs Market Segmentation: By the product type, the market is...
Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) Sees Significant Increase in Short Interest. Posted by admin on Apr 15th, 2022.
Digital strategy consultancy SparkOptimus has appointed Susanne van Santen to the role of Chief Financial Officer. Susanne van Santen brings...
Other Companies in Oakland
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $300M | 1536 | 2% | N/A |
#2 | $593.8M | 1571 | 7% | N/A |
#3 | $362.2M | 1617 | 10% | N/A |
#4 | $75M | 1625 | 6% | N/A |
#5 | $623.7M | 1650 | -2% | N/A |